Cannabinoids in models of chronic inflammatory conditions

Phytochemistry Reviews

Volumn 4, Issue 1, 2005, Pages 11-18

  Mechoulam, Raphael ^a   Sumariwalla, Percy F ^b   Feldmann, Marc ^b   Gallily, Ruth ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cannabidiol; HU 320; Murine collagen induced arthritis; Rheumatoid arthritis; TNF

Indexed keywords

AJULEMIC ACID; CANNABIDIOL; CANNABIDIOL DERIVATIVE; CANNABINOID; CANNABIS; COLLAGEN TYPE 2; ENDOTOXIN; GAMMA INTERFERON; HU 320; LIPOPOLYSACCHARIDE; PSYCHOTROPIC AGENT; REACTIVE OXYGEN METABOLITE; TETRAHYDROCANNABINOL; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTHROPATHY; BLOOD LEVEL; CHRONIC INFLAMMATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DOSE RESPONSE; DRUG BINDING; DRUG EFFECT; DRUG SAFETY; DRUG STRUCTURE; EX VIVO STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INTERFERON PRODUCTION; KNEE; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SYNOVIOCYTE;

ANIMALIA; CANNABIS SATIVA; MURINAE;

EID: 23944434153     PISSN: 15687767     EISSN: 1572980X     Source Type: Journal    
DOI: 10.1007/s11101-004-1534-1     Document Type: Conference Paper

References (52)

1. R Adams 1941-1942 Marihuana Harvey Lect 37 168 197
2. S Agurell M Halldin JE Lingren A Ohlsson M Widman H Gillespie L Hollister 1986 Pharmacokinetics and metabolism of delta-1-tetrahydrocannabinol and other cannabinoids with emphasis on man Pharmacol. Revs 38 21 43
3. TF Brunner 1973 Marijuana in ancient Greece and Rome? The literary evidence Bull. Hist. Med 47 344 355
4. Burstein S (1989) Delta-1-THC-7-oic Acid and Analgetic and Anti-inflammatory Agents. US Patent 4,847,290
5. SH Burstein CA Audette A Breuer WA Devane S Colodner SA Doyle R Mechoulam 1992 Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic and leukocyte anti-adhesion activities J. Med. Chem 35 3135 3141
6. Burstein 2001 Ajulemic acid. Drugs Future 26 342 345
7. S Burstein 2001 Therapeutic potential of ajulemic acid (CT3) F Grotenherman E. Russo Cannabis and Cannabinoids Haworth Press New York 381 388
8. 1 receptor participation Adv. Exp. Med. Biol 493 207 214
9. R Campbell Thompson 1949 A Dictionary of Assyrian Botany The British Academy London 220 222
10. IC Chopra RN Chopra 1957 The use of cannabis drugs in India Bull. Narc 9 4 29
11. A Christison 1851 On the natural history, action and uses of Indian hemp Monthly J. Med. Sci 13 26 45 and 177-121
12. EZ Dajani KR Larsen J Taylor NE Dajani TG Shahwan SD Neeleman MS Taylor MT Dayton GN Mir 1999 1,1-dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: A novel orally effective cannabinoid with analgesic and anti-inflammatory properties J. Pharmacol. Exp. Ther 291 31 38
13. WA Devane FA Dysarz 3rd MR Johnson LS Melvin AC Howlett 1988 Determination and characterization of a cannabinoid receptor in rat brain Mol. Pharmacol 34 605 613
14. WA Devane A Breuer T Sheskin TUC Jarbe M Eisen R Mechoulam 1992a A novel probe for the cannabinoid receptor J. Med. Chem 35 2065 2069
15. WA Devane L Hanus A Breuer RG Pertwee LA Stevenson G Griffm D Gibson A Mandelbaum A Etinger R Mechoulam 1992b Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1946 1949
16. Dioscorides (1934) The Greek Herbal. In: Gunther RT, (ed) Oxford University Press, pp. 390-391, plant drawings 165 and 166
17. M Donovan 1845 On the physical and medicinal qualities of Indian hemp (Cannabis indica) Dublin J. Med. Sci 26 368 402 and 459-461
18. EA Formukong AT Evans FJ Evans 1988 Analgesic and anti-inflammatory activity of constituents of Cannabis sativa L Inflammation 12 361 371
19. E Fride R Mechoulam 1993 Pharmacological activity of the cannabinoid agonist anandamide, a brain constituent Eur. J. Pharmacol 231 313 314
20. Y Gaoni R Mechoulam 1964 Isolation structure and partial synthesis of active constituent of hashish J. Amer. Chern. Soc 86 1646 1647
21. AJ Hampson M Grimaldi J Axelrod D Wink 1998 Cannabidiol and (-)delta(9)-tetrahydrocannabinol are neuroprotective antioxidants Proc. Natl. Acad. Sci. (USA) 95 8268 8273
22. AC Howlett RM Fleming 1984 Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes Mol. Pharmacol 26 532 538
23. AC Howlett TM Champion GH Wilken R Mechoulam 1990 Stereochemical effects of 11-OH-delta-8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor Neuropharmacol 291 161 165
24. AC Howlett F Barth TI Bonner G Cabral P Casellas WA Devane CC Felder M Herkenham K Mackie BR Martin R Mechoulam RG Pertwee 2002 lnternation Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol. Rev 54 161 202
25. TW Klein C Newton K Larsen L Lu I Perkins L Nong H Friedman 2003 The cannabinoid system and immune modulation J. Leukoc. Biol 74 486 489
26. DM Lambert S Vandevoorde KO Jonsson CJ Fowler 2002 The palmitoylethanolamide family: A new class of anti-inflammatory agents? Curr. Med. Chem 9 663 674
27. AM Malfait R Gallily PF Sumariwalla AS Malik E Andreakos R Mechoulam M Feldmann 2000 The non-psychoactive cannabis-constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis Proc. Natl. Acad. Sci. (USA) 97 9561 9566
28. LA Matsuda SJ Lolait MJ Brownstein AC Young TI Bonner 1990 Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 561 564
29. 1-tetrahydrocannabinol, the major active constituent of hashish. Tetrahededron Lett. 1109-1111
30. R Mechoulam 1970 Marihuana chemistry Review. Science 168 1159 1166
31. R Mechoulam Z Ben-Zvi S Agurell IM Nilsson JLG Nilsson H Edery Y Grunfeld 1973 Delta-6-tetrahydrocannabinol-7-oic acid, a urinary delta-6-THC metabolite - isolation and synthesis Experientia 29 1193 1195
32. R. Mechoulam 1986 The Pharmacohistory of Cannabis sativa R Mechoulam Cannabinoids as Therapeutic Agents CRC Press, Inc Boca Raton Fl 1 19
33. R Mechoulam JJ Feigenbaum N Lander M Segal TUC Jarbe AJ Hiltunen P Consroe 1988 Enantiomeric cannabinoids: Stereospecificity of psychotropic activity Experientia 44 762 764
34. R Mechoulam S Ben-Shabat L Hanus M Ligumsky NE Kaminski AR Schatz A Gopher S Almog BR Martin DR Compton 1995 Identification of a andogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem. Pharmacol 50 83 90
35. R Mechoulam S Ben-Shabat 1999 From gan-zi-gun-nu to anandamide and 2-arachidonoyl-glycerol, the ongoing story of Cannabis Nat. Prod. Rep 16 131 143
36. R Mechoulam L. Hanus 2002 Cannabidiol: An overview of some chemical and pharmacological aspects. Part I: Chemical Aspects Chem. Phys. Lipids 121 35 43
37. R Mechoulam LA Parker R Gallily 2002 Cannabidiol: An overview of some pharmacological aspects J. Clin. Pharmacol 42 11S 19S
38. D Melck T Bisogno L De-Petrocellis P Beaulieu AS Rice V Di Marzo 2002 Cannabimimetic eicosanoids in cancer and inflammation: an update Adv. Exp. Med. Biol 507 381 386
39. S Munro KL Thomas M Abu-Shaar 1993 Molecular characterization of a peripheral receptor for cannabinoids Nature 365 61 65
40. O'Shaugnessy WB (1843) On the preparations of the Indian hemp, or Gunjah. Trans. Med. Physical Soc. Bengal, 421-461
41. MH Rhee Z Vogel J Barg M Bayewitch R Levy L Hanus A Breuer R Mechoulam 1997 Cannabinol derivatives: Binding to cannabinoid receptors and inhibition of adenylylcyclase J. Med. Chem 40 3228 3233
42. Rosenkrantz H, Fleischman RW, Grant RJ (1981) Toxicity of short-term administration of cannabinoids to rhesus monkeys. Toxicol. Ap
43. MD Roth GC Baldwin DP Tashkin 2002 Effects of delta-9- tetrahydrocannabinol on human immune function and host defense Chem. Phys. Lipids 121 229 239
44. J Russel Reynolds 1890 Therapeutic uses and toxic effects of Cannabis indica Lancet 1 637 638
45. R Sancho MA Calzado V Di Marzo G Appendino E Munoz 2003 Anandamide inhibits nuclear factor-KB activation through a cannabinoid receptor-independent pathway Mol. Pharmacol 63 429 438
46. MD Srivastava BI Srivastava B Brouhard 1998 Delta- 9-tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells Immunopharmacol 40 179 1885
47. T Sugiura S Kondo A Sukagawa S Nakane A Shinoda K Itoh A Yamashita K Waku 1995 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem. Biophys. Res. Commun 215 89 97
48. E Sulcova R Mechoulam E Fride 1998 Biphasic effects ofanandamide Pharmacol. Biochem. Behav 59 347 353
49. Sumariwalla PF, Gallily R, Tchilibon S, Fride E, Mechoulam R, Feldmann M (2004) A novel synthetic non-psychoactive cannabinoid acid (HU-320) with anti-inflammatory properties in murine collagen-induced arthritis. Arthritis Rheumat. (in press)
50. AR Todd 1946 Hashish Experientia 2 55 60
51. CE Turner MA Elsohly EG Boeren 1980 Constituents of Cannabis sativa L. XVII. A review of the natural constituents J. Nat. Prod 43 169 234
52. B Watzl P Scuderi RR Watson 1991 Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro Int. J. Immunopharmacol 13 1091 1097